About: AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: economic evaluation protocol for a randomised controlled trial-based equivalence study

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: economic evaluation protocol for a randomised controlled trial-based equivalence study Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 April 2019

Attributes	Values
rdf:type	Item
description	artículu científicu espublizáu n'abril de 2019 (ast) scientific article published on 01 April 2019 (en) im April 2019 veröffentlichter wissenschaftlicher Artikel (de) наукова стаття, опублікована у квітні 2019 (uk)
publication date	wds:Q64089684-70C91BE6-572C-4CEB-82C7-6C3E9BE60560
publication date	2019-04-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q64089684-0F1F1AD3-765B-40C1-99D9-5B666C648718
language of work or name	English
cites work	wds:Q64089684-006F640C-5C0D-4F2C-942E-A3FE4EB8364F wds:Q64089684-0B188D38-A771-4732-BD3C-7DC1E35DDD87 wds:Q64089684-22D63E4E-14BA-4436-9690-28D07E59C620 wds:Q64089684-2453AAFD-72AD-4B43-B5ED-3EE8C6E75E81 wds:Q64089684-30208258-B74F-4074-A902-966BE16A1194 wds:Q64089684-33884803-B4C4-41F3-A45F-EF6C1372442F wds:Q64089684-3708DAD8-E602-4BA9-8429-4D967EE737FD wds:Q64089684-395E5474-9824-44C9-95D4-A3ECDA66A02F wds:Q64089684-4A8580AB-7AC1-4F35-B4D7-290FED120E31 wds:Q64089684-6CFAD95A-0C27-48C0-A232-1C98EACA7807 wds:Q64089684-AC1A606F-5142-45F7-A009-81CFB861422C wds:Q64089684-B63CA1E3-5026-4F95-AD56-973FB4CB65F6 wds:Q64089684-D1AC424A-CD29-425D-ABC8-5AAEAB75B81C wds:Q64089684-D64853C4-588D-4D3C-A102-9BFA733A292E wds:Q64089684-DD8DC059-75B3-4EB4-B81E-FB5D86742C7C wds:Q64089684-DE536852-D254-4171-8623-60BBDEC28247 wds:Q64089684-F833F29F-6F1B-4993-B915-956F98B984CD
cites work	Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and Zimbabwe Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. Good practice guidelines for decision-analytic modelling in health technology assessment: a review and consolidation of quality assessment Cryptococcal meningitis treatment strategies in resource-limited settings: a cost-effectiveness analysis Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS-associated acute cryptococcal meningitis: a randomized, double-blind clinical trial of efficacy and safety Cost effectiveness of cryptococcal antigen screening as a strategy to prevent HIV-associated cryptococcal meningitis in South Africa Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis Cost and quality of life analysis of HIV self-testing and facility-based HIV testing and counselling in Blantyre, Malawi Forgotten but not gone: HIV-associated cryptococcal meningitis Step-by-step guideline for disease-specific costing studies in low- and middle-income countries: a mixed methodology Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa. Short-course High-dose Liposomal Amphotericin B for Human Immunodeficiency Virus–associated Cryptococcal Meningitis: A Phase 2 Randomized Controlled Trial AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial The COUNTDOWN Study Protocol for Expansion of Mass Drug Administration Strategies against Schistosomiasis and Soil-Transmitted Helminthiasis in Ghana Experimental Models of Short Courses of Liposomal Amphotericin B for Induction Therapy for Cryptococcal Meningitis Emerging concepts in HIV-associated cryptococcal meningitis Noninferiority testing in cost-minimization studies: Practical issues concerning power analysis
author name string	wds:Q64089684-0B2A8E4E-E71A-4386-A5D5-B4DEC645A323 wds:Q64089684-16C1FE66-0EF5-42FB-A3DD-56BE44466F6D wds:Q64089684-1749734B-4285-4F57-BB57-89AB617CD034 wds:Q64089684-354BFE62-7FDA-410B-B01D-004351468863 wds:Q64089684-48FF1C6F-A63B-4E52-B1C4-D28DDD6B0616 wds:Q64089684-4E3EBA39-414F-4B61-A4A2-78469A5AF4EA wds:Q64089684-62F7CC5E-670E-4845-8223-3C895B6A5BD9 wds:Q64089684-7BA4EB11-DBAA-4A17-ACDB-200121C9B4A6 wds:Q64089684-7F023992-FC93-4E8D-AE85-C91A1AF89A2B wds:Q64089684-8F67C4F0-8583-4482-8093-E8E729FFEC98 wds:Q64089684-96C8C1CB-BDCE-476A-A35C-E658CCF5F001 wds:Q64089684-981F48FD-035A-4D7D-93A9-A05437BEA2D8 wds:Q64089684-9BD71914-C9C2-402C-831E-DBAB6244BFBE wds:Q64089684-A1A31927-15B4-41E8-9DD0-4E5F53646267 wds:Q64089684-AEC52497-AB67-44AA-82CD-EEFD9A871355 wds:Q64089684-BB8464E3-D80E-48C6-BF1F-68BB6A775E7D wds:Q64089684-C777E25C-2FD8-4726-913F-B40966C48582 wds:Q64089684-C8989ACF-F2C3-4D8F-9CCE-21C464824D61 wds:Q64089684-CA3BB95F-EC4E-4829-86F6-C4148BCE3BA2 wds:Q64089684-CF89D6CC-4BCF-47E6-903A-9C0105DF15F1 wds:Q64089684-D466F5C9-FA4F-4114-B89D-1F8EF64034B9 wds:Q64089684-E1044D9C-1F2E-45C1-96A0-F80C3D1A14DA
author name string	David G Lalloo Radha Rajasingham Tao Chen Chiratidzo E Ndhlovu Shabbar Jaffar Graeme Meintjes Mosepele Mosepele Angela Loyse Cecilia Kanyama Chimwemwe Chawinga Admire Hlupeni Melanie Alufandika Nabila Youssouf Shepherd Shamu Katlego Tsholo Funeka Bango David Stephen Lawrence Ebbie Gondwe Eltas Dziwani Ponego Lloyd Ponatshego Sile F Molloy Sumaya Sayed
rdfs:label	AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: economic evaluation protocol for a randomised controlled trial-based equivalence study (en)
skos:prefLabel	AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: economic evaluation protocol for a randomised controlled trial-based equivalence study (en)
name	AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: economic evaluation protocol for a randomised controlled trial-based equivalence study (en)
author	wds:Q64089684-1CC91905-BEDF-4694-972F-4CB5F7A111BF wds:Q64089684-2BC38299-16BA-44FE-AB94-3B95779867F4 wds:Q64089684-3D64704A-96AC-4DF9-BAE2-56821E54F4B3 wds:Q64089684-62DA2D99-3767-4EDA-8254-532E0F378E5A wds:Q64089684-68C234AC-E813-4943-BD95-6D429190783B wds:Q64089684-6BC4C8DE-49FE-4705-966A-6480BCA976CE wds:Q64089684-78DB5768-99E2-4AD8-8F3D-6672A8F19635 wds:Q64089684-7C813B88-D49B-47F9-872C-C9F604A6231A wds:Q64089684-8F3B5133-F003-4026-9D06-C63B7A8F942D wds:Q64089684-A7EA8D4F-D933-4881-A958-77586FC8CC8F

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software